Tracking blood flow in the laboratory is an important tool for studying ailments like migraines or strokes and designing new ways to address them. Blood flow is also routinely measured in the clinic, and laser speckle contrast imaging is one way of measuring these changes; however, this technique requires professional-grade imaging equipment, which limits its use.
Fluorescence imaging is the most widely used method for analyzing the molecular composition of biological specimens. Target molecules, when they are present, can be "tagged" with a fluorescent label and made visible. This highly sensitive technique, which is used in screening blood for cancer cells and studying biochemical reactions, is very good at detecting molecules present in extremely low concentrations.
A joint BYU-Utah research team is developing a new breast cancer screening technique that has the potential to reduce false positives, and, possibly, minimize the need for invasive biopsies. The group has created an MRI device that could improve both the process and accuracy of breast cancer screening by scanning for sodium levels in the breast.
Olive Medical to Showcase 1080p HD All-In-One Visualization System for ENT Procedures at AAO-HNSF Annual MeetingSeptember 26, 2013 4:30 pm | by PR Newswire | News | Comments
Olive Medical Corporation of Salt Lake City, UT announces the showcase of the OVS1 ALL-IN-ONE HD Visualization system at the AAO-HNSF Annual Meeting & OTO Expo in Vancouver, BC Canada from September 29 – October 2 at BOOTH #542. The OVS1 has achieved both 510(k) and CE mark clearance and is the world's only lightweight, compact complete HD visualization system for in-office head and neck procedures.
IMRIS Inc. and Varian Medical Systems today announced that data presented here earlier this week at the American Society for Radiation Oncology (ASTRO) Annual Meeting demonstrates the potential to direct state-of-the-art radiation treatments using diagnostic-quality MR images at each treatment session.
Calgary Scientific today shared that its ResolutionMD diagnostic medical imaging software was formally evaluated by clinicians during a structured research study at the Mayo Clinic in Arizona and determined to be significantly faster than the two PACS and desktop image-viewing systems currently in use at the facility.
Researchers are using computer simulations to investigate how ultrasound and tiny bubbles injected into the bloodstream might break up blood clots, limiting the damage caused by a stroke in its first hours. Strokes are the most common cause of long-term disability in the United States and the third most common cause of death.
Food and Drug Administration officials say they will begin regulating a new wave of applications and gadgets that work with smartphones to take medical readings and help users monitor their health. With the rise of the iPhone, Android and other mobile devices has come a flood of applications designed to help people stay healthy.
Researchers have made an exciting breakthrough – developing a first-of-its-kind imaging tool to examine myelin damage in multiple sclerosis (MS). An extremely difficult disease to diagnose, the tool will help physicians diagnose patients earlier, monitor the disease’s progression, and evaluate therapy efficacy.
In the field of medical technology, wireless devices are seeing some of the most broad-reaching growth. This is due mostly in part to the wide range of applications that wireless medicine encompasses. Mobi Health News reports that the top ten areas wireless medicine has directly benefited include: Alzheimer’s, asthma, breast cancer, COPD, depression, diabetes, heart failure, hypertension, obesity, and sleep disorders.
Intuitive Surgical said the FDA expanded the 510(k) clearance for its FireFly fluorescence imaging system to use during gallbladder surgery using its da Vinci robotic surgery device. The device uses a video camera and fluorescent dye to show blood flow in vessels and tissue, by causing blood to appear green and bloodless tissue as gray, according to a press release.
Given Imaging has announced that Japan's Pharmaceuticals and Medical Devices Agency has granted approval for the PillCam SB 3 system. The innovative technology in this third-generation system will provide physicians throughout Japan with the most advanced PillCam capsule endoscopy technology to detect and monitor small bowel diseases, such as Crohn's disease.
The medical device and diagnostics market is set to grow at 4.5 percent per year (CAGR) between 2012 and 2018, totalling $455 billion in 2018, according to the newly-released EvaluateMedTech World Preview 2013, Outlook to 2018: The Future of Medtech report from market intelligence firm Evaluate Ltd.
Analogic Corporation, enabling the world's medical imaging and aviation security technology, today announced that it has acquired the remaining ownership stake in PocketSonics, Inc., a privately held ultrasound technology firm based in Charlottesville, Virginia.
CAS DataLoggers Engineer Terry Nagy has worked on a uniquely challenging data acquisition application which highlights the effectiveness of Delphin data loggers. A medical equipment manufacturer had a customer in a hospital who was experiencing problems with a particular CT scan machine that would reset in the middle of the procedure, which cost significant time as patients often had to be scanned again.
Researchers at MIT have developed a microfluidic device that mimics the flow of cancer cells through a system of blood vessels. Using high-resolution time-lapse imaging, the researchers captured the moments as a cancer cell squeezes its way through a blood vessel wall into the surrounding extracellular matrix.
A new, non-invasive imaging technique, magnetic resonance elastography, can now help physicians accurately detect fibrosis in children with chronic liver disease. A new study shows that MRE detects such chronic diseases as non-alcoholic fatty liver disease, which is increasingly common in children and teens, affecting an estimated 13 percent of adolescents.
The researchers have developed a method that improves the delimitation of tumors in medical images. As they explained, “when the doctor decides where tumor tissue should be separated from healthy tissue, our algorithm ensures that he/she is never going choose the worst option because the best solution is automatically offered.”
A lens invented at The Ohio State University combines the focusing ability of a human eye with the wide-angle view of an insect eye to capture images with depth. The results could offer surgical imaging that enables doctors to see inside the human body like never before.
A lens invented at The Ohio State University combines the focusing ability of a human eye with the wide-angle view of an insect eye to capture images with depth. The results could be smartphones that rival the photo quality of digital cameras, and surgical imaging that enables doctors to see inside the human body like never before.
GE Healthcare issued its 2nd imaging system fall warning in as many months after the company discovered that certain Advantx and Innova systems were installed without 4 screws that hold up the overhead video monitors. There have been no reports of the systems falling, GE noted, but the company said that the missing screws may increase the risk of falls, asking hospitals to check their systems and report any issues.
Scientists seeking new ways to fight cancer often try to understand the subtle, often invisible, changes to DNA, proteins, cells, and tissue that alter the body's normal biology and cause disease. Now, to aid in that fight, a team of researchers has developed a sophisticated new optical imaging tool that enables scientists to look deep within tumors and uncover their inner workings.
With funding from the National Institute for Health Research, experts at The University of Nottingham have developed a highly accurate prototype technique which can produce a detailed ‘spectroscopic fingerprint’ of each tissue layer removed during surgery.
Logical Images, the Rochester-based company that created the nation's only widely used diagnostic decision tool, VisualDx, announced today that it has been awarded a U.S. patent for its unique visual diagnostic process and system that, in addition to other features, selectively presents and displays images based upon descriptive characteristics of a patient.
Surgery is the cornerstone of oncology treatment, and molecularly-targeted fluorescent imaging agents have the potential to guide surgical resection by highlighting the biological margins of the disease. However, development and testing of such molecular imaging agents has been lacking.